These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26393949)

  • 21. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
    Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
    Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-tumour effects of triple therapy with octreotide, galanin and serotonin in comparison with those of 5-fluorouracil/leukovorin on human colon cancer.
    Tjomsland V; El-Salhy M
    Int J Oncol; 2005 Aug; 27(2):427-32. PubMed ID: 16010424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models.
    Chang YS; Adnane J; Trail PA; Levy J; Henderson A; Xue D; Bortolon E; Ichetovkin M; Chen C; McNabola A; Wilkie D; Carter CA; Taylor IC; Lynch M; Wilhelm S
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):561-74. PubMed ID: 17160391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regorafenib suppresses sinusoidal obstruction syndrome in rats.
    Okuno M; Hatano E; Nakamura K; Miyagawa-Hayashino A; Kasai Y; Nishio T; Seo S; Taura K; Uemoto S
    J Surg Res; 2015 Feb; 193(2):693-703. PubMed ID: 25266603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
    Marzola P; Degrassi A; Calderan L; Farace P; Nicolato E; Crescimanno C; Sandri M; Giusti A; Pesenti E; Terron A; Sbarbati A; Osculati F
    Clin Cancer Res; 2005 Aug; 11(16):5827-32. PubMed ID: 16115922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KRAS exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer.
    Camaj P; Primo S; Wang Y; Heinemann V; Zhao Y; Laubender RP; Stintzing S; Giessen-Jung C; Jung A; Gamba S; Bruns CJ; Modest DP
    Future Oncol; 2015; 11(13):1919-29. PubMed ID: 26161928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Irinophore C™, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancer.
    Neijzen R; Wong MQ; Gill N; Wang H; Karim T; Anantha M; Strutt D; Waterhouse D; Bally MB; Tai IT; Ng SS; Yapp DT
    J Control Release; 2015 Feb; 199():72-83. PubMed ID: 25497312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of Notch-1 in Resistance to Regorafenib in Colon Cancer Cells.
    Mirone G; Perna S; Shukla A; Marfe G
    J Cell Physiol; 2016 May; 231(5):1097-105. PubMed ID: 26419617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of the Mechanism of Action of Regorafenib for Clinical Practice.
    Prager G
    Clin Adv Hematol Oncol; 2019 Aug; 17 Suppl 12(8):5-13. PubMed ID: 32720933
    [No Abstract]   [Full Text] [Related]  

  • 31. In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human colon cancer cell HCT 116 xenografts in nude mice: evaluation of tumor growth and immunohistochemistry.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Oncol Rep; 2005 Mar; 13(3):421-5. PubMed ID: 15706410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of etoricoxib, a cyclooxygenase-2 selective inhibitor on aberrant crypt formation and apoptosis in 1,2 dimethyl hydrazine induced colon carcinogenesis in rat model.
    Sharma P; Kaur J; Sanyal SN
    Nutr Hosp; 2010; 25(1):39-48. PubMed ID: 20204254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited tumor growth (HT29) in vivo under RO205-2349 is due to increased apoptosis and reduced cell volume but not to decreased proliferation rate.
    Katoh M; Feldhaus S; Schnitzer T; Bauer S; Schumacher U
    Cancer Lett; 2004 Jul; 210(1):7-15. PubMed ID: 15172115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapy.
    Sabir A; Schor-Bardach R; Wilcox CJ; Rahmanuddin S; Atkins MB; Kruskal JB; Signoretti S; Raptopoulos VD; Goldberg SN
    AJR Am J Roentgenol; 2008 Jul; 191(1):133-9. PubMed ID: 18562736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new apparatus and surgical technique for the dual perfusion of human tumor xenografts in situ in nude rats.
    Dauchy RT; Dauchy EM; Mao L; Belancio VP; Hill SM; Blask DE
    Comp Med; 2012 Apr; 62(2):99-108. PubMed ID: 22546915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STAT3 mediates regorafenib-induced apoptosis in hepatocellular carcinoma.
    Tai WT; Chu PY; Shiau CW; Chen YL; Li YS; Hung MH; Chen LJ; Chen PL; Su JC; Lin PY; Yu HC; Chen KF
    Clin Cancer Res; 2014 Nov; 20(22):5768-76. PubMed ID: 25248379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irradiation-dependent effects on tumor perfusion and endogenous and exogenous hypoxia markers in an A549 xenograft model.
    Fokas E; Hänze J; Kamlah F; Eul BG; Lang N; Keil B; Heverhagen JT; Engenhart-Cabillic R; An H; Rose F
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1500-8. PubMed ID: 20637978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activated natural killer cell tumor retention and cytokine production in colon tumor using a tissue-isolated model.
    Ribeiro U; Whiteside TL; Basse PH; Safatle-Ribeiro AV; Huneke CE; Posner MC
    J Surg Res; 1999 Mar; 82(1):78-87. PubMed ID: 10068530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of early therapeutic response to sorafenib in renal cell carcinoma xenografts by dynamic contrast-enhanced and diffusion-weighted MR imaging.
    Jeon TY; Kim CK; Kim JH; Im GH; Park BK; Lee JH
    Br J Radiol; 2015 Sep; 88(1053):20150163. PubMed ID: 26133222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticancer effects of KI-10F: a novel compound affecting apoptosis, angiogenesis and cell growth in colon cancer.
    Hong SW; Jung KH; Choi MJ; Kim DY; Lee HS; Zheng HM; Li GY; El-Deeb IM; Park BS; Lee SH; Hong SS
    Int J Oncol; 2012 Nov; 41(5):1715-22. PubMed ID: 22941304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.